Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1933 IndustriesTGIFF -4.44% Earnings per Share (Diluted) is $0.00 as of Apr. 2026. The stock has 2 warning signs investors should review. Among 784 Drug Manufacturers companies, 1933 Industries ranks better than 93.49% on this metric.
1933 Industries's EPS (Basic) for the
three
months ended in Apr. 2026 was $0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 was $0.00.
During the past 3 years, the average EPS without NRIGrowth Rate was 64.30% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 52.60% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 26.20% per year.
During the past 13 years, 1933 Industries's highest 3-Year average EPS without NRI Growth Rate was 64.30% per year. The lowest was -54.40% per year. And the median was 34.65% per year.
1933 Industries (OTCPK:TGIFF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
1933 Industries Earnings per Share (Diluted) Related Terms
1933 Industries Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for 1933 Industries's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1933 Industries Earnings per Share (Diluted) Chart
TGIFF vs ZTS: Earnings per Share (Diluted) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1933 Industries PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's PE Ratio distribution charts can be found below:
* The bar in red indicates where 1933 Industries's PE Ratio falls into.
1933 Industries Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
1933 Industries's Earnings Per Share (Diluted) for the fiscal year that ended in Jul. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.00 mean?
1933 Industries (TGIFF) has a Earnings per Share (Diluted) of $0.00 as of Apr. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on 1933 Industries and its competitors. According to the industry distribution chart, 1933 Industries ranks #51 out of 784 companies in the Drug Manufacturers industry, placing it in the top 6.5%.
Is 1933 Industries' Earnings per Share (Diluted) too high?
1933 Industries' current Earnings per Share (Diluted) is $0.00. Based on the distribution chart, 1933 Industries ranks #51 out of 784 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does 1933 Industries' Earnings per Share (Diluted) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, 1933 Industries ranks #51 out of 784 companies for Earnings per Share (Diluted). This places 1933 Industries in the top 7% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 9.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.80, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on 1933 Industries and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1933 Industries's current Earnings per Share (Diluted) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1933 Industries stock overvalued right now?
Based on GuruFocus' analysis, 1933 Industries (TGIFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 57% below its estimated fair value. The current Earnings per Share (Diluted) is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For 1933 Industries (TGIFF), the current Earnings per Share (Diluted) is $0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGIFF has been successfully added to your 
